![Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial. | Semantic Scholar Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b726610f4b4a72da85d3efd2f7e901458d44f625/3-Figure1-1.png)
Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial. | Semantic Scholar
![A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability - Journal of Pharmaceutical Sciences A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/2046472858/2057563418/gr1.jpg)
A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability - Journal of Pharmaceutical Sciences
How Pulmozyme (dornase alfa) addresses abnormal mucus In laboratory tests, Pulmozyme has been shown to thin and loosen the mucus
![NASAL INHALATION OF DORNASE ALFA (PULMOZYME) IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC RHINOSINUSITIS | Midwest Sinus and Allergy NASAL INHALATION OF DORNASE ALFA (PULMOZYME) IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC RHINOSINUSITIS | Midwest Sinus and Allergy](http://www.midwestsinus.com/wp-content/uploads/2013/09/pul_mode_of_action_g_medium.jpg)